Pathway2targets links a disease-related pathway signal to molecular candidates by aligning pathway information with gene or protein datasets. Enrichment analysis can identify biological processes represented in the data, while interaction-network analysis examines relationships among components. Target-prioritization methods then organize these candidates, helping translate a broad pathway observation into specific molecular hypotheses for testing.
Each analytical component contributes a different kind of evidence. Enrichment analysis emphasizes whether genes or proteins are associated with particular pathways or processes. Interaction-network analysis adds information about relationships among molecular components, and prioritization combines these signals to highlight candidates connected to important disease biology. Together, these analyses make pathway findings more interpretable than a single data view.
Ranking helps focus attention on molecular candidates associated with disease-relevant processes. Pathway context connects each candidate to important biological activity, while network relationships can indicate links with other relevant components. The resulting order does not establish therapeutic validity; instead, it creates a structured set of hypotheses that researchers can examine through experimental validation.
Pathway-level analysis describes coordinated biological context, but it may not identify which individual gene or protein should be examined first. Pathway2targets narrows that gap by connecting pathway findings with molecular datasets and ranking candidate components. This target-oriented view supports focused follow-up while preserving the relationship between each candidate and the disease-associated process behind its selection.
A typical workflow begins by assembling disease-associated pathway information together with relevant gene or protein data. Researchers then apply enrichment analysis, interaction-network analysis, or another target-prioritization strategy to connect the datasets and identify prominent candidates. The candidates are organized into a ranked output, which guides the selection of molecular hypotheses for subsequent experimental validation.
Researchers can use Pathway2targets when high-throughput biological data reveal pathway-level patterns that require more focused interpretation. The ranked candidates may support drug-discovery studies, biomarker development, or investigations of disease mechanisms. By relating molecular components to pathway context, the approach helps convert complex biological observations into testable questions and priorities for experimental follow-up.